Back to dashboard
CommercialCoverageHigh impact

11.07.01ac, Hematopoietic Stem Cell Transplantation

Independence Blue Cross·Hematology, Oncology·Medical Policy
Effective date
Oct 20, 2025
We identified it
Jun 19, 2026
Days to comply

Summary

Independence Blue Cross updated their medical necessity criteria for Hematopoietic Stem Cell Transplantation procedures. This change affects coverage determinations and approval requirements for stem cell transplant services under commercial insurance plans.

Action Required

Action needed
Before October 20, 2025: Billing team must review updated medical necessity criteria for all hematopoietic stem cell transplant cases. Update prior authorization request templates to align with new criteria requirements. Providers must ensure documentation meets revised medical necessity standards to avoid claim denials for transplant services.